Profile picture

Associate Professor Chiara Melloni

Cytokinetics, Durham (United States of America)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial
Presentation
Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial

ESC 365 is supported by